4//SEC Filing
Onaitis Matthew 4
Accession 0001209191-11-016705
CIK 0001339455other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:25 PM ET
Size
9.7 KB
Accession
0001209191-11-016705
Insider Transaction Report
Form 4
Onaitis Matthew
VP, General Counsel
Transactions
- Award
Stock option (right to buy)
2011-03-07+100,000→ 100,000 totalExercise: $2.93Exp: 2021-03-06→ Common Stock (100,000 underlying) - Award
Common Stock
2011-03-07+30,000→ 94,037 total - Award
Common Stock
2011-03-07+50,000→ 144,037 total
Footnotes (4)
- [F1]These shares are represented by restricted stock units ("RSUs"). 1/3 of these RSUs will vest on 12/31/2011, 1/3 of these RSUs will vest on 12/31/2012 and 1/3 of these RSUs will vest on 12/31/2013, subject to the reporting person's continued service to the Company through each such vesting date.
- [F2]These shares are represented by RSUs. These RSUs will vest during the first quarter of 2012 on the second business day following the public release of the Comany's audited financial statements for the ficsl year ended December 31, 2011, subject to the Company's attainment of certain corporate performance objectives during 2011 and subject to the reporting person's continued service to the Company through such vesting date.
- [F3]1/4 of the total number of shares of common stock subject to the option vest on 3/7/2012, and 1/36th of the total remaining number of shares of common stock subject to the option vest on the first day of each calendar month thereafter, subject to the reporting person's continued service to the Company through each such vesting date.
- [F4]Not applicable.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001362822
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 5:25 PM ET
- Size
- 9.7 KB